PIEFX
Price
$27.17
Change
+$0.07 (+0.26%)
Updated
Sep 11 closing price
Net Assets
89.41M
RNWHX
Price
$107.05
Change
-$0.71 (-0.66%)
Updated
Sep 11 closing price
Net Assets
90.01B
Interact to see
Advertisement

PIEFX vs RNWHX

PIEFX vs RNWHX Comparison Chart in %
View a ticker or compare two or three
VS
PIEFX vs. RNWHX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PIEFX is a Buy and RNWHX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 90B vs. PIEFX (89.4M). PIEFX pays higher dividends than RNWHX: PIEFX (1.27) vs RNWHX (1.15). PIEFX was incepted earlier than RNWHX: PIEFX (9 years) vs RNWHX (11 years). PIEFX (1.76) is less costly to investors than RNWHX (0.72). RNWHX is a more actively managed with annual turnover of: 46.00 vs. PIEFX (26.00). RNWHX has a lower initial minimum investment than PIEFX: RNWHX (250) vs PIEFX (1000000). PIEFX annual gain was more profitable for investors over the last year : 39.96 vs. RNWHX (17.19). PIEFX return over 5 years is better than : 34.86 vs. RNWHX (17.68).
PIEFXRNWHXPIEFX / RNWHX
Total Expense Ratio0.990.72138%
Annual Report Gross Expense Ratio1.760.72244%
Fund Existence9 years11 years-
Gain YTD33.69516.447205%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets89.4M90B0%
Annual Yield % from dividends1.271.15111%
Returns for 1 year39.9617.19233%
Returns for 3 years107.8453.84200%
Returns for 5 years34.8617.68197%
Returns for 10 yearsN/A111.44-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLPEX46.310.28
+0.61%
Fidelity Advisor Low-Priced Stock C
FACDX64.25N/A
N/A
Fidelity Advisor Health Care A
EXHAX26.61N/A
N/A
Manning & Napier Pro-Blend Max Term S
LMCFX35.98N/A
N/A
Lord Abbett Mid Cap Stock F
MSAWX22.51N/A
N/A
Morgan Stanley Inst Asia Opp C